Quick Answer
Emmaus Life Sciences, Inc. reported Shares Outstanding of 70.19 million shares for fiscal year 2025.
Emmaus Life Sciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 70.19M | +9.9% |
| 2024 | 63.87M | +3.3% |
| 2023 | 61.85M | +24.7% |
| 2022 | 49.58M | +0.6% |
| 2021 | 49.31M | +0.7% |
| 2020 | 48.99M | +1.1% |
| 2019 | 48.47M | +1.7% |
| 2019 | 47.67M | +27.7% |
| 2018 | 37.34M | +404.1% |
| 2018 | 7.41M | +72.3% |
| 2017 | 4.30M | +121.5% |
| 2016 | 1.94M | +278.8% |
| 2015 | 512,405 | -99.5% |
| 2014 | 101.67M | +9.7% |
| 2013 | 92.72M | +4743.7% |
| 2012 | 1.91M | +2.3% |
| 2011 | 1.87M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 63.87M | +0.0% | +0.0% |
| June 30, 2025 | 63.87M | +0.0% | +0.0% |
| March 31, 2025 | 63.87M | +3.3% | +0.0% |
| December 31, 2024 | 63.87M | +3.3% | +0.0% |
| September 30, 2024 | 63.87M | +19.1% | +0.0% |
| June 30, 2024 | 63.87M | +19.1% | +3.3% |
| March 31, 2024 | 61.85M | +21.4% | +0.0% |
| December 31, 2023 | 61.85M | +24.7% | +15.3% |
- Emmaus Life Sciences, Inc. showed an increase of +9.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2011–2025 period, Emmaus Life Sciences, Inc.’s shares outstanding has grown by 3650.7% (from 1.87 million shares to 70.19 million shares).
- The most recent figure is from Emmaus Life Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: